Parkman Healthcare Partners as of Dec. 31, 2021
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 84 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Iqvia Holdings (IQV) | 4.6 | $21M | 73k | 282.14 | |
United Therapeutics Corporation (UTHR) | 4.3 | $20M | 90k | 216.08 | |
Danaher Corporation (DHR) | 4.3 | $19M | 59k | 329.01 | |
UnitedHealth (UNH) | 4.2 | $19M | 38k | 502.13 | |
Dex (DXCM) | 3.9 | $18M | 33k | 536.95 | |
Avantor (AVTR) | 3.8 | $17M | 408k | 42.14 | |
Aclaris Therapeutics (ACRS) | 3.3 | $15M | 1.0M | 14.54 | |
CVS Caremark Corporation (CVS) | 3.0 | $14M | 133k | 103.16 | |
Hca Holdings (HCA) | 2.9 | $13M | 51k | 256.92 | |
Seagen | 2.8 | $13M | 81k | 154.60 | |
Natera (NTRA) | 2.6 | $12M | 125k | 93.39 | |
Xenon Pharmaceuticals (XENE) | 2.5 | $11M | 361k | 31.24 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 2.5 | $11M | 100k | 111.96 | |
Horizon Therapeutics Pub L SHS | 2.4 | $11M | 101k | 107.76 | |
Codexis (CDXS) | 2.3 | $11M | 340k | 31.27 | |
Cooper Cos Com New | 2.2 | $9.9M | 24k | 418.93 | |
Alnylam Pharmaceuticals (ALNY) | 2.2 | $9.8M | 58k | 169.59 | |
Charles River Laboratories (CRL) | 2.2 | $9.8M | 26k | 376.78 | |
Immunic (IMUX) | 2.1 | $9.3M | 974k | 9.57 | |
Peregrine Pharmaceuticals (CDMO) | 1.9 | $8.5M | 290k | 29.18 | |
Catalent (CTLT) | 1.7 | $7.8M | 61k | 128.03 | |
Apollo Endosurgery | 1.7 | $7.7M | 919k | 8.43 | |
R1 Rcm | 1.7 | $7.7M | 300k | 25.49 | |
Irhythm Technologies (IRTC) | 1.6 | $7.3M | 62k | 117.68 | |
IDEXX Laboratories (IDXX) | 1.6 | $7.2M | 11k | 658.43 | |
Abbvie (ABBV) | 1.5 | $7.0M | 52k | 135.40 | |
Biosante Pharmaceuticals (ANIP) | 1.4 | $6.3M | 137k | 46.08 | |
Gossamer Bio (GOSS) | 1.4 | $6.2M | 546k | 11.31 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $5.5M | 400k | 13.85 | |
Arcus Biosciences Incorporated (RCUS) | 1.0 | $4.7M | 117k | 40.47 | |
Insulet Corporation (PODD) | 1.0 | $4.5M | 17k | 266.06 | |
Fulcrum Therapeutics (FULC) | 1.0 | $4.4M | 250k | 17.69 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.9 | $4.1M | 99k | 41.90 | |
Dentsply Sirona (XRAY) | 0.9 | $4.1M | 74k | 55.79 | |
Keros Therapeutics (KROS) | 0.9 | $4.1M | 70k | 58.52 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.9 | $3.9M | 65k | 60.86 | |
Harvard Bioscience (HBIO) | 0.8 | $3.8M | 537k | 7.05 | |
Brooks Automation (AZTA) | 0.8 | $3.8M | 37k | 103.11 | |
Sutro Biopharma (STRO) | 0.7 | $3.3M | 221k | 14.88 | |
Tenet Healthcare Corp Com New (THC) | 0.7 | $3.3M | 40k | 81.70 | |
Supernus Pharmaceuticals (SUPN) | 0.7 | $3.1M | 105k | 29.16 | |
Kodiak Sciences (KOD) | 0.7 | $3.0M | 35k | 84.78 | |
Repligen Corporation (RGEN) | 0.6 | $2.7M | 10k | 264.83 | |
Alphatec Hldgs Com New (ATEC) | 0.6 | $2.7M | 235k | 11.43 | |
Imago Biosciences | 0.6 | $2.6M | 110k | 23.71 | |
Veracyte (VCYT) | 0.6 | $2.6M | 62k | 41.20 | |
Stereotaxis Com New (STXS) | 0.6 | $2.6M | 413k | 6.20 | |
Nurix Therapeutics (NRIX) | 0.6 | $2.5M | 88k | 28.96 | |
Ionis Pharmaceuticals (IONS) | 0.5 | $2.4M | 80k | 30.43 | |
Madrigal Pharmaceuticals (MDGL) | 0.5 | $2.4M | 29k | 84.72 | |
AngioDynamics (ANGO) | 0.5 | $2.4M | 88k | 27.58 | |
Altimmune Com New (ALT) | 0.5 | $2.4M | 264k | 9.16 | |
Schrodinger (SDGR) | 0.5 | $2.4M | 68k | 34.83 | |
Outset Med (OM) | 0.5 | $2.2M | 47k | 46.09 | |
Alpha Teknova (TKNO) | 0.5 | $2.2M | 105k | 20.48 | |
Health Catalyst (HCAT) | 0.5 | $2.1M | 53k | 39.62 | |
Performant Finl (PFMT) | 0.5 | $2.0M | 850k | 2.41 | |
89bio (ETNB) | 0.4 | $2.0M | 152k | 13.07 | |
Semler Scientific (SMLR) | 0.4 | $2.0M | 21k | 91.65 | |
Axogen (AXGN) | 0.4 | $1.9M | 207k | 9.37 | |
Akoya Biosciences (AKYA) | 0.4 | $1.9M | 125k | 15.31 | |
Mirati Therapeutics | 0.4 | $1.9M | 13k | 146.66 | |
Sientra | 0.4 | $1.8M | 492k | 3.67 | |
Repro-Med Systems (KRMD) | 0.4 | $1.8M | 598k | 3.00 | |
Halozyme Therapeutics (HALO) | 0.4 | $1.7M | 41k | 40.21 | |
Phathom Pharmaceuticals (PHAT) | 0.3 | $1.5M | 78k | 19.67 | |
Forma Therapeutics Hldgs SHS | 0.3 | $1.4M | 100k | 14.22 | |
Kiniksa Pharmaceuticals Com Cl A | 0.3 | $1.3M | 114k | 11.77 | |
Tela Bio (TELA) | 0.3 | $1.3M | 104k | 12.80 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $1.2M | 36k | 34.74 | |
Surface Oncology | 0.3 | $1.2M | 259k | 4.78 | |
Mannkind Corp Com New (MNKD) | 0.3 | $1.2M | 266k | 4.37 | |
Recro Pharma | 0.2 | $1.1M | 646k | 1.71 | |
Rapid Micro Biosystems Class A Com (RPID) | 0.2 | $1.1M | 100k | 10.64 | |
Opiant Pharmaceuticals | 0.2 | $1.1M | 31k | 33.62 | |
Castlight Health CL B | 0.2 | $964k | 626k | 1.54 | |
Biolinerx Sponsored Ads (BLRX) | 0.2 | $874k | 429k | 2.04 | |
Quanterix Ord (QTRX) | 0.2 | $848k | 20k | 42.40 | |
Icad Com New (ICAD) | 0.2 | $744k | 103k | 7.20 | |
Zymeworks | 0.2 | $682k | 42k | 16.38 | |
Oncternal Therapeutics | 0.1 | $657k | 289k | 2.27 | |
Molecular Templates | 0.1 | $579k | 148k | 3.92 | |
Vera Therapeutics Cl A (VERA) | 0.1 | $576k | 22k | 26.72 | |
Verastem | 0.1 | $376k | 183k | 2.05 |